cyclosporine has been researched along with Injuries, Spinal Cord in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (12.12) | 18.2507 |
| 2000's | 18 (54.55) | 29.6817 |
| 2010's | 11 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batty, NJ; Biernaskie, J; Fenrich, KK; Fouad, K; Führmann, T; Lucas-Osma, AM; May, Z; Raposo, P; Shoichet, M; Stykel, MG; Torres-Espín, A | 1 |
| Hall, ED; Springer, JE; Sullivan, PG; Visavadiya, NP | 1 |
| Chen, ZR; Guo, HH; Jin, QH; Lu, ZD; Ma, Y | 1 |
| Antonios, JP; Ciacci, JD; Cleary, DR; Farah, GJ; Martin, JR; Pham, MH | 1 |
| Jazayeri, SB; Rahimi-Movaghar, V | 1 |
| Ban, DX; Chang, J; Cheng, SZ; Feng, SQ; Gao, SJ; Liu, Y; Ning, GZ; Wang, HJ; Wang, LL | 1 |
| Franco-Bourland, RE; Grijalva, I; Guízar-Sahagún, G; Ibarra, A; Madrazo, I; Martínez-Cruz, A; Rodríguez-Balderas, CA | 1 |
| Bravo, G; Hong, E; Ibarra, A; Rojas, G; Romero, SE | 1 |
| Albermann, S; Barry, FP; Dockery, P; Garcia, Y; Hynes, J; McMahon, SS; Moran, C; O'Brien, T; Rooney, GE; Windebank, AJ | 1 |
| Grotenhuis, A; Hurtado, A; Nandoe Tewarie, RD; Oudega, M; Rahiem, ST; Ritfeld, GJ; Roos, RA | 1 |
| Boniface, G; Endres, R; Feifel, R; Gimenez y Ribotta, M; Lonjon, N; Perrin, FE; Privat, A | 1 |
| Hu, JG; Lü, HZ; Wang, FC; Wang, YX; Zhou, JS | 1 |
| Delaviz, H; Joghataie, MT; Mehdizadeh, M; Mirzaei, A; Roozbehi, A | 1 |
| Hodgetts, SI; Plant, GW; Simmons, PJ | 1 |
| Fairbanks, CA; Wilcox, GL; Yezierski, RP; Yu, CG | 1 |
| Fischer, I; Murray, M; Shibata, M; Shumsky, JS; Tessler, A; Tobias, CA; Tuszynski, MH | 1 |
| Diaz-Ruiz, A; Guizar-Sahagún, G; Ibarra, A; Perez-Severiano, F; Ríos, C; Segovia, J; Vergara, P | 2 |
| Bunge, MB; Hill, CE; Moon, LD; Wood, PM | 1 |
| Connors, T; Fischer, I; Hayashi, Y; Murray, M; Otsuka, T; Shumsky, JS; Tessler, A | 1 |
| Cui, YJ; Fukuda, S; Matsumoto, M; Sakabe, T; Tsuruta, S; Wakamatsu, H; Yamashita, A | 1 |
| Diaz-Ruiz, A; Ibarra, A | 1 |
| Buenrostro, M; Correa, D; Flores, N; Garcia, E; Guizar-Sahagun, G; Hernández, E; Ibarra, A; Lomeli, J; Madrazo, I; Martiñón, S; Pineda, D | 1 |
| McEwen, ML; Springer, JE; Sullivan, PG | 1 |
| Choi, YK; Jeong, ES; Kim, HC; Lee, CH; Nam, KH; Park, HJ; Park, JI; Won, YS | 1 |
| McEwen, ML; Ravikumar, R; Springer, JE | 1 |
| Castañeda-Hernández, G; Correa, D; Espitia, AL; Flores-Murrieta, FJ; Franco-Bourland, R; Grijalva, I; Guízar-Sahagún, G; Ibarra, A; Kretschmer, R; López, RM; Madrazo, I; Odor, A; Salgado-Ceballos, H | 1 |
| Castañeda-Hernández, G; Correa, D; Flores-Murrieta, FJ; Franco-Bourland, R; Grijalva, I; Guízar-Sahagún, G; Ibarra, A; Madrazo, I; Martínez, S; Reyes, J | 1 |
| Chow, SY; Fischer, I; Himes, BT; Huang, W; Liu, Y; Moul, J; Tessler, A | 1 |
| Correa, D; Diaz-Ruiz, A; Duarte, I; Grijalva, I; Guizar-Sahagun, G; Ibarra, A; Rios, C | 1 |
| Correa, D; Diaz-Ruiz, A; Duarte, I; Grijalva, I; Guizar-Sahagun, G; Ibarra, A; Madrazo, I; Rios, C | 1 |
| Gold, BG | 1 |
| Fugaccia, I; Rabchevsky, AG; Scheff, SW; Sullivan, PG | 1 |
3 review(s) available for cyclosporine and Injuries, Spinal Cord
| Article | Year |
|---|---|
Immunosuppressive mechanisms for stem cell transplant survival in spinal cord injury.
Topics: Adjuvants, Immunologic; Allografts; Animals; Basiliximab; Cells, Cultured; Clinical Trials as Topic; Cyclosporine; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Human Embryonic Stem Cells; Humans; Immunosuppressive Agents; Induced Pluripotent Stem Cells; Male; Mice; Mycophenolic Acid; Oligodendrocyte Precursor Cells; Rats; Spinal Cord Injuries; Tacrolimus; Transplantation, Autologous | 2019 |
Protective effect of cyclosporin-A in spinal cord injury: an overview.
Topics: Animals; Apoptosis; Calcineurin; Central Nervous System; Cyclosporine; Humans; Spinal Cord Injuries | 2006 |
Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders.
Topics: Animals; Brain Injuries; Carpal Tunnel Syndrome; Cyclosporine; Humans; Immunophilins; Immunosuppressive Agents; Ligands; Nerve Regeneration; Nervous System Diseases; Spinal Cord Injuries; Tacrolimus; Tacrolimus Binding Protein 1A | 2000 |
30 other study(ies) available for cyclosporine and Injuries, Spinal Cord
| Article | Year |
|---|---|
Cyclosporine-immunosuppression does not affect survival of transplanted skin-derived precursor Schwann cells in the injured rat spinal cord.
Topics: Animals; Cyclosporine; Disease Models, Animal; Female; Nerve Regeneration; Peripheral Nerves; Rats, Inbred F344; Recovery of Function; Schwann Cells; Spinal Cord; Spinal Cord Injuries | 2017 |
Post-Injury Treatment with NIM811 Promotes Recovery of Function in Adult Female Rats after Spinal Cord Contusion: A Dose-Response Study.
Topics: Animals; Cyclosporine; Dose-Response Relationship, Drug; Female; Neuroprotective Agents; Random Allocation; Rats; Rats, Long-Evans; Recovery of Function; Spinal Cord Injuries | 2018 |
Therapeutic efficacy of cyclosporin A against spinal cord injury in rats with hyperglycemia.
Topics: Animals; Apoptosis; Apoptosis Inducing Factor; Cyclophilins; Cyclosporine; Disease Models, Animal; Female; Gene Expression Regulation; Hyperglycemia; Interleukin-10; Motor Activity; Nerve Regeneration; Neuroglia; Neurons; Neuroprotective Agents; Peptidyl-Prolyl Isomerase F; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Streptozocin; Tumor Necrosis Factor-alpha | 2018 |
When do we start Basso, Beattie, and Bresnahan assessment after experimental spinal cord injury?
Topics: Animals; Axons; Cyclosporine; Female; Motor Neurons; Spinal Cord; Spinal Cord Injuries | 2013 |
New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes.
Topics: Animals; Cyclosporine; Drug Carriers; Drug Liberation; Female; GAP-43 Protein; Gene Expression; Gene Products, tat; Lactic Acid; Liposomes; Nanoparticles; Nerve Regeneration; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Spinal Cord; Spinal Cord Injuries | 2017 |
Lack of neuroprotection with pharmacological pretreatment in a paradigm for anticipated spinal cord lesions.
Topics: Analysis of Variance; Animals; Cyclosporine; Disease Models, Animal; Erythropoietin; Female; Locomotion; Melatonin; Methylprednisolone; Neuroprotective Agents; Postoperative Complications; Rats; Rats, Long-Evans; Recombinant Proteins; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Time Factors | 2009 |
Acute, subacute and chronic effect of cyclosporin-A on mean arterial pressure of rats with severe spinal cord contusion.
Topics: Analysis of Variance; Animals; Blood Pressure; Cyclosporine; Disease Models, Animal; Female; Immunosuppressive Agents; Rats; Rats, Wistar; Spinal Cord Injuries; Time Factors | 2008 |
Effect of cyclosporin A on functional recovery in the spinal cord following contusion injury.
Topics: Animals; Collagen; Cyclosporine; Drug Evaluation, Preclinical; Female; Hindlimb; Microscopy, Electron, Scanning; Nerve Regeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries | 2009 |
Reducing macrophages to improve bone marrow stromal cell survival in the contused spinal cord.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Female; Graft Survival; Immunohistochemistry; Immunosuppressive Agents; Macrophages; Methylprednisolone; Minocycline; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Stromal Cells | 2010 |
Potential adverse effects of cyclosporin A on kidneys after spinal cord injury.
Topics: Animals; Cell Transplantation; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Graft Rejection; Immunosuppressive Agents; Kidney Diseases; Male; Rats; Rats, Wistar; Spinal Cord Injuries; Treatment Outcome | 2011 |
Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation.
Topics: Animals; Antimetabolites; Bromodeoxyuridine; Cell Differentiation; Cell Survival; Cells, Cultured; Cyclosporine; Female; Green Fluorescent Proteins; Immunohistochemistry; Immunosuppressive Agents; Locomotion; Motor Neurons; Myelin Sheath; Neural Stem Cells; Oligodendroglia; Rats; Rats, Sprague-Dawley; Receptor-CD3 Complex, Antigen, T-Cell; Recovery of Function; Spinal Cord; Spinal Cord Injuries; T-Lymphocytes | 2010 |
The effects of cyclosporin-A on functional outcome and axonal regrowth following spinal cord injury in adult rats.
Topics: Animals; Axons; Cyclosporine; Disease Models, Animal; Female; Hindlimb; Motor Activity; Motor Neurons; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Time Factors | 2012 |
Human mesenchymal precursor cells (Stro-1⁺) from spinal cord injury patients improve functional recovery and tissue sparing in an acute spinal cord injury rat model.
Topics: Animals; Bone Marrow Cells; Cyclosporine; Disease Models, Animal; Female; Graft Rejection; Humans; Immunohistochemistry; Immunosuppressive Agents; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Rats, Nude; Recovery of Function; Sensory Receptor Cells; Serotonergic Neurons; Spinal Cord Injuries | 2013 |
Effects of agmatine, interleukin-10, and cyclosporin on spontaneous pain behavior after excitotoxic spinal cord injury in rats.
Topics: Agmatine; Animals; Cyclosporine; Disease Models, Animal; Excitatory Amino Acid Agonists; Grooming; Immunosuppressive Agents; Interleukin-10; Male; Pain; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Time Factors | 2003 |
Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration.
Topics: Animals; Atrophy; Axotomy; Biotin; Brain-Derived Neurotrophic Factor; Cell Count; Cell Size; Cell Survival; Cyclosporine; Dextrans; Female; Fibroblasts; GAP-43 Protein; Green Fluorescent Proteins; Immunohistochemistry; Immunosuppressive Agents; Luminescent Proteins; Nerve Regeneration; Neurons; Neurotrophin 3; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Red Nucleus; Spinal Cord Injuries | 2003 |
Cyclosporin-A inhibits inducible nitric oxide synthase activity and expression after spinal cord injury in rats.
Topics: Animals; Cyclosporine; Disease Models, Animal; Female; I-kappa B Proteins; Immunosuppressive Agents; Nerve Degeneration; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Spinal Cord Injuries; Transcription, Genetic | 2004 |
Cyclosporin-A inhibits constitutive nitric oxide synthase activity and neuronal and endothelial nitric oxide synthase expressions after spinal cord injury in rats.
Topics: Actins; Animals; Blotting, Western; Calcineurin Inhibitors; Cyclosporine; Enzyme Inhibitors; Female; Immunosuppressive Agents; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Wistar; Spinal Cord Injuries | 2005 |
Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Cell Survival; Cyclosporine; Female; Humans; Immunosuppressive Agents; Necrosis; Nitroblue Tetrazolium; Placenta; Rats; Rats, Inbred F344; Receptor, Nerve Growth Factor; Schwann Cells; Spinal Cord Injuries | 2006 |
Immunosuppression with either cyclosporine a or FK506 supports survival of transplanted fibroblasts and promotes growth of host axons into the transplant after spinal cord injury.
Topics: Animals; Animals, Genetically Modified; Axons; Combined Modality Therapy; Cyclosporine; Female; Fibroblasts; Graft Survival; Immunosuppressive Agents; Nerve Regeneration; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Spinal Cord Injuries; Tacrolimus | 2005 |
The effects of cyclosporin A and insulin on ischemic spinal cord injury in rabbits.
Topics: Animals; Blood Glucose; Brain; Capillary Permeability; Cyclosporine; Hindlimb; Insulin; Lumbar Vertebrae; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Movement; Neurons; Neuroprotective Agents; Paraplegia; Rabbits; Spinal Cord; Spinal Cord Injuries; Spinal Cord Ischemia | 2006 |
Cyclosporin-A enhances non-functional axonal growing after complete spinal cord transection.
Topics: Animals; Axons; Blotting, Western; Cyclosporine; Electrophysiology; Female; GAP-43 Protein; Immunohistochemistry; Nerve Regeneration; Neuroprotective Agents; Pyramidal Tracts; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord Injuries | 2007 |
Pretreatment with the cyclosporin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats.
Topics: Animals; Biomechanical Phenomena; Chromatography, High Pressure Liquid; Contusions; Cyclosporine; Female; Mass Spectrometry; Mitochondria; Oxygen Consumption; Rats; Rats, Long-Evans; Reactive Oxygen Species; Spinal Cord Injuries; Synapses | 2007 |
Upregulation of galectin-3 by Corynebacterium kutscheri infection in the rat lung.
Topics: Animals; Corynebacterium; Corynebacterium Infections; Cyclosporine; Disease Models, Animal; Galectin 3; Gene Expression Regulation, Bacterial; Immunocompromised Host; Immunosuppressive Agents; Lung; Macrophages, Alveolar; Male; Necrosis; Pneumonia, Pneumococcal; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; RNA, Bacterial; Specific Pathogen-Free Organisms; Spinal Cord Injuries; Staphylococcus aureus | 2007 |
Post-treatment with the cyclosporin derivative, NIM811, reduced indices of cell death and increased the volume of spared tissue in the acute period following spinal cord contusion.
Topics: Animals; Apoptosis; Cyclosporine; Cytochromes c; Cytosol; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Female; Image Processing, Computer-Assisted; Neuroprotective Agents; Rats; Rats, Long-Evans; Spinal Cord Injuries; Time | 2007 |
Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Cyclosporine; Female; Half-Life; Immunosuppressive Agents; Injections, Intraperitoneal; Rats; Spinal Cord Injuries | 1996 |
Use of cyclosporin-A in experimental spinal cord injury: design of a dosing strategy to maintain therapeutic levels.
Topics: Animals; Cyclosporine; Female; Immunosuppressive Agents; Injections, Intraperitoneal; Rats; Spinal Cord; Spinal Cord Injuries | 1996 |
Application of recombinant adenovirus for in vivo gene delivery to spinal cord.
Topics: Adenoviridae; Animals; Antibody Formation; beta-Galactosidase; Cyclosporine; Female; Gene Transfer Techniques; Genes, Reporter; Immunosuppressive Agents; Injections, Spinal; Rats; Rats, Sprague-Dawley; Recombination, Genetic; Spinal Cord Injuries; Transgenes | 1997 |
Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats.
Topics: Animals; Cyclosporine; Depression, Chemical; Female; Immunosuppressive Agents; Lipid Peroxidation; Rats; Rats, Wistar; Spinal Cord; Spinal Cord Injuries | 1999 |
Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone.
Topics: Animals; Cyclosporine; Drug Combinations; Female; Lipid Peroxides; Methylprednisolone; Neuroprotective Agents; Rats; Rats, Wistar; Spinal Cord Injuries; Survival Analysis | 2000 |
Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing.
Topics: Animals; Cyclosporine; Female; Immunosuppressive Agents; Male; Motor Activity; Paralysis; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Stereotaxic Techniques; Thoracic Vertebrae | 2001 |